This study will examine the use of the ivWatch Model 400 to monitor PIV sites in pediatric patients. Half the participants will be monitored by the device without infiltration notifications and the other half will be monitored by the device with infiltration notifications enabled.
Age range
17 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Time Infiltration Detected by Nurse
Timeframe: Participants will be followed for the duration of intravenous therapy, an expected duration of up to 1 week
Infiltration Sensitivity
Timeframe: Participants will be followed for the duration of intravenous therapy, an expected duration of up to 1 week
Notification Rate of ivWatch Device
Timeframe: Participants will be followed for the duration of intravenous therapy, an expected duration of up to 1 week